中證網訊（記者(zhe) 宋維東(dong)）東(dong)北制(zhi)藥(yao)(yao)（000597）6月20日晚公(gong)告(gao)稱，公(gong)司持(chi)股(gu)(gu)5%以(yi)上股(gu)(gu)東(dong)東(dong)藥(yao)(yao)集團及(ji)一致行(xing)動人(ren)盛京金控集團擬通過公(gong)開征集受讓方的方式協議轉讓所持(chi)東(dong)北制(zhi)藥(yao)(yao)股(gu)(gu)份。二者(zhe)本(ben)次擬轉讓股(gu)(gu)份合計2.55億股(gu)(gu)，占東(dong)北制(zhi)藥(yao)(yao)總股(gu)(gu)本(ben)的18.91%。

　　東藥(yao)集(ji)團(tuan)(tuan)與盛京(jing)金(jin)控集(ji)團(tuan)(tuan)為一致行動人(ren)，最終(zhong)控制(zhi)人(ren)均(jun)為沈陽市國資委。其中，東藥(yao)集(ji)團(tuan)(tuan)擬轉(zhuan)讓所(suo)持(chi)東北制(zhi)藥(yao)股(gu)(gu)份2.11億股(gu)(gu)，占東北制(zhi)藥(yao)總股(gu)(gu)本的(de)15.64%；盛京(jing)金(jin)控集(ji)團(tuan)(tuan)擬轉(zhuan)讓所(suo)持(chi)東北制(zhi)藥(yao)股(gu)(gu)份4402.7萬(wan)股(gu)(gu)，占東北制(zhi)藥(yao)總股(gu)(gu)本的(de)3.27%。

　　公(gong)(gong)(gong)告顯示，本(ben)次(ci)股份轉讓(rang)意(yi)向(xiang)受(shou)讓(rang)方的征集條(tiao)件其(qi)中(zhong)要求，意(yi)向(xiang)受(shou)讓(rang)方最近三年連(lian)續盈利，最近一年合(he)并資(zi)產總額不(bu)低(di)于300億元(yuan)，資(zi)產負債率不(bu)超過60%；意(yi)向(xiang)受(shou)讓(rang)方及(ji)其(qi)實(shi)(shi)際(ji)控制(zhi)人(ren)(ren)(ren)不(bu)存在《上市(shi)(shi)公(gong)(gong)(gong)司收購(gou)管理(li)辦法(fa)》規定的不(bu)得(de)收購(gou)上市(shi)(shi)公(gong)(gong)(gong)司的情形；意(yi)向(xiang)受(shou)讓(rang)方及(ji)其(qi)實(shi)(shi)際(ji)控制(zhi)人(ren)(ren)(ren)應具有管理(li)實(shi)(shi)體企業及(ji)上市(shi)(shi)公(gong)(gong)(gong)司的經(jing)驗，具有明晰的經(jing)營發(fa)展(zhan)戰略，具備促(cu)進上市(shi)(shi)公(gong)(gong)(gong)司持續發(fa)展(zhan)和改善上市(shi)(shi)公(gong)(gong)(gong)司法(fa)人(ren)(ren)(ren)治理(li)結構的能力，具有促(cu)進產業發(fa)展(zhan)及(ji)產業整合(he)的能力，能夠維護上市(shi)(shi)公(gong)(gong)(gong)司資(zi)產及(ji)業務完整性(xing)，保(bao)證上市(shi)(shi)公(gong)(gong)(gong)司穩定持續發(fa)展(zhan)等。